Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

Arterburn D, Curtis LH, Toh S, Bradley MC, D'Alessio D, Duchovny N, Hines D, Narain K, Parekh A, Skinner A, Wee CC, Wong JB, Wright DR, Osganian SK, Hales C. Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-25-05468. Epub ahead of print. PMID: 42372278.


Related Posts